Login / Signup

Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.

Charalampos CharalampousUtkarsh GoelPrashant KapoorMoritz BinderFrancis K BuadiJoselle Madonna CookDavid DingliAngela DispenzieriAmie L FonderMorie A GertzWilson GonsalvesSuzanne R HaymanMiriam A HobbsYi L HwaTaxiarchis V KourelisMartha Q LacyNelson LeungYi LinRahma WarsameRobert A KyleSundararajan Vincent RajkumarShaji K Kumar
Published in: Blood cancer journal (2023)
Keyphrases
  • multiple myeloma
  • acute lymphoblastic leukemia
  • bone marrow